Genetic mapping of modifier loci affecting malignant hypertension in TGRmRen2 rats

Kidney International

Volumn 56, Issue 2, 1999, Pages 414-420

  Kantachuvesiri, Surasak ^a   Haley, Chris S ^a   Fleming, Stewart ^a   Kurian, Katarna ^a   Whitworth, Caroline E ^a   Wenham, Philip ^a   Kotelevtsev, Yuri ^a   Mullins, John J ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cardiovascular; Gene mapping; Hypertension; Renin angiotensin system; Transgenic rat

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 10; CHROMOSOME 17; ENZYME ACTIVITY; FEMALE; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENETIC MODEL; HISTOPATHOLOGY; MALE; MALIGNANT HYPERTENSION; NONHUMAN; PENETRANCE; PRIORITY JOURNAL; PROGENY; RAT; TRANSGENE;

EID: 0032782571     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00571.x     Document Type: Article

References (34)

1. 1. HOUSTON MC: Pathophysiology, clinical aspects, and treatment of hypertensive crises. Prog Cardiovasc Dis 22:99-148, 1989
2. 2. LEISHMAN AWD: Hypertension-treated and untreated: A study of 400 cases. BMJ 1:1361-1363, 1959
3. 3. KEITH NM, WAGENER HP, BARKER NW: Some different types of essential hypertension: Their course and prognosis. Am J Med Sci 196:332-339, 1939
4. 4. WEBSTER J, PETRIE JC, JEFFERS TA, LOVELL HG: Accelerated hypertension: Patterns of mortality and clinical factors affecting outcome in treated patients. Q J Med 86:485-493, 1993
5. 5. LIP G, BEEVERS M, BEEVERS G: The failure of malignant hypertension to decline: A survey of 24 years experience in a multiracial population in England. J Hypertens 12:1297-1305, 1994
6. 6. WILSON C, BYROM FB: Renal changes in malignant hypertension. Lancet 1:136-139, 1939
7. 7. KINCAID-SMITH P: Renal pathology in hypertension and the effects of treatment. Br J Clin Pharmacol 13:107-115, 1982
8. 8. KINCAID-SMITH P: Understanding malignant hypertension. Aust N Z J Med 11 (Suppl):64-68, 1981
9. 9. UNITED STATES RENAL DATA SYSTEM: USRDS 1993 Annual Data Report. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, 1992
10. 10. YOUNG EW, MAUGER EA, JIANG KH, PORT FK, WOLFE RA: Socioeconomic status and end-stage renal disease in the United States. Kidney Int 45:907-911, 1994
11. 11. WHITWORTH CE, FLEMING S, CUMMING AD, MORTON JJ, BURNS NJT, WILLIAMS BC, MULLINS JJ: Spontaneous development of malignant hypertension in transgenic Ren-2 rats. Kidney Int 46:1528-1532, 1994
12. 12. WHITWORTH CE, FLEMING S, KOTELEVTSEV Y, MANSON L, BROOKER GA, CUMMING AD, MULLINS JJ: A genetic model of malignant phase hypertension in rats. Kidney Int 47:529-535, 1995
13. 13. MULLINS JJ, PETERS J, GANTEN D: Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344:541-544, 1990
14. 14. JACOB HJ, BROWN DM, BUNKER RK, DALY MJ, DZAU VJ, GOODMAN A, KOIKE G, KREN V, KURTZ T, LERNMARK A, LEVAN G, MAO Y-P, PETTERSSON A, PRAVENEC M, SIMON JS, SZPIRER C, SZPIRER J, TROLLIET MR, WINER ES, LANDER ES: A genetic linkage map of the laboratory rat, Rattus norvegicus. Nature Genet 9:63-69, 1995
15. 15. MAGUIRE GA, PRICE CP: A continuous monitoring spectrophotometric method for the measurement of angiotensin-converting enzyme in human serum. Ann Clin Biochem 22:204-210, 1985
16. 16. GREEN P, FALLS K, CROOKS S: Documentation for Cri-map (version 2.4). St. Louis, Washington University School of Medicine, 1992
17. 17. HALEY CS, KNOTT SA: A simple regression method for mapping quantitative trait loci in line crosses using flanking markers. Heredity 69:315-324, 1992
18. 18. VISSCHER PM, HALEY CS, KNOTT SA: Mapping QTLs for binary traits in backcross and F2 populations. Genet Res 68:55-63, 1996
19. 19. LANDER E, KRUGLYAK L: Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nature Genet 11:241-247, 1995
20. 20. FLEISS JL: Statistical Methods for Rates and Proportions. New York, John Wiley and Sons, 1981
21. 21. MONTGOMERY HE, KIERNAN LA, WHITWORTH CE, FLEMING S, UNGER T, GOHLKE P, MULLINS JJ, MCEWAN JR: Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mRen2)27. J Hypertens 16:635-643, 1998
22. 22. KREUTZ R, HUBNER N, GANTEN D, LINDPAINTNER K: Genetic-linkage of the ace gene to plasma angiotensin-converting enzyme-activity but not to blood-pressure: A quantitative trait locus confers identical complex phenotypes in human and rat hypertension. Circulation 92:2381-2384, 1995
23. 23. CAMBIEN F, POIRTER O, LECERF L, EVANS A, CAMBOU JP, ARVEILER D, LUC G, BARD JM, BARA L, RICARD S, TIRET L, AMOUYEL P, ALHENC-GELAS F, SOUBRIER F: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
24. 24. IWAI N, OHMICHI N, NAKAMURA Y, KINOSHITA M: DD genotype of the angiotensin I converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 90:2622-2628, 1994
25. 25. SCHUNKERT H, HENSE HW, HOLMER SR, STENDER M, PERZ S, KEIL U, LORELL BH, RIEGGER GAJ: Association between a deletion polymorphism of the angiotensin converting enzyme gene and left ventricular hypertrophy. N Engl J Med 330:1634-1638, 1994
26. 26. HUNLEY TE, JULIAN BA, PHILIPS JA, SUMMAR ML, YOSHIDA H, HORN RG, BROWN NJ, FOGO A, ICHIKAWA I, KON V: Angiotensin-converting enzyme gene polymorphism: Potential silent motif and impact on progression in IgA nephropathy. Kidney Int 49:571-577, 1996
27. 27. YOSHIDA H, KURIYAMA S, ATSUMI Y, TOMONARI F, MITARAI T, HAMAGUCHI L, KUBO H, KAWAGUCHI Y, KON V, MATSUOKA K, ICHIKAWA I, SAKAI O: Angiotensin-I converting enzyme gene polymorphism in non-insulin dependent diabetes-mellitus. Kidney Int 50:657-664, 1996
28. 28. PONTREMOLI R, SOFIA A, TIROTTA A, RAVERA M, NICOLELLA C, VIAZZI F, BEZANTE GP, BORGIA L, BOBOLA N, RAVAZZOLO R, SACCHI G, DEFERRARI G: The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension. J Am Soc Nephrol 7:2550-2558, 1996
29. 29. MARKUS HS, BARLEY J, LUNT R, BLAND JM, JEFFREY S, CARTER ND, BROWN MM: Angiotensin-converting enzyme gene deletion polymorphism: A new risk factor for lacunar stroke but not carotid atheroma. Stroke 26:1329-1333, 1995
30. 1 receptor subtype. Circ Res 73:413-423, 1993
31. 31. SCHELLING P, FISCHER H, GANTEN D: Angiotensin and cell growth: A link to cardiovascular hypertrophy? J Hypertens 9:3-15, 1991
32. 32. GIBBONS GH, DZAU VJ: The emerging concept of vascular remodelling. N Engl J Med 330:1431-1438, 1994
33. 1 receptor gene expression in transgenic (mRen-2)27 rats. Br J Pharmacol 121:134-140, 1997
34. 34. TIRET L, BONNARDEAUX A, POIRIER O, MARQUES-VIDAL P, EVANS A, ARVEILER D, LUC G, KEE F, DUCIMETIERE P, SOUBRIER F, CAMBIEN F: Synergistic effects of angiotensin-converting enzyme gene and angiotensin II type 1 receptor gene polymorphisms in risk of myocardial infarction. Lancet 344:910-913, 1992